These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 33898960)

  • 1. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial.
    Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar TB; Hagström H; Stål P
    JHEP Rep; 2021 Jun; 3(3):100256. PubMed ID: 33898960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial.
    Hansen CD; Gram-Kampmann EM; Hansen JK; Hugger MB; Madsen BS; Jensen JM; Olesen S; Torp N; Rasmussen DN; Kjærgaard M; Johansen S; Lindvig KP; Andersen P; Thorhauge KH; Brønd JC; Hermann P; Beck-Nielsen H; Detlefsen S; Hansen T; Højlund K; Thiele MS; Israelsen M; Krag A
    Ann Intern Med; 2023 Jan; 176(1):10-21. PubMed ID: 36508737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macronutrient composition and its effect on body composition changes during weight loss therapy in patients with non-alcoholic fatty liver disease: Secondary analysis of a randomized controlled trial.
    Lindqvist C; Holmer M; Hagström H; Petersson S; Tillander V; Brismar TB; Stål P
    Nutrition; 2023 Jun; 110():111982. PubMed ID: 36940624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 12-week intermittent calorie restriction compared to standard of care in patients with nonalcoholic fatty liver disease: a randomized controlled trial.
    Lee HA; Moon H; Kim Y; Lee HA; Kim HY
    Trials; 2023 Aug; 24(1):490. PubMed ID: 37533096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that supports the prescription of low-carbohydrate high-fat diets: a narrative review.
    Noakes TD; Windt J
    Br J Sports Med; 2017 Jan; 51(2):133-139. PubMed ID: 28053201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD.
    Oh S; Tsujimoto T; Kim B; Uchida F; Suzuki H; Iizumi S; Isobe T; Sakae T; Tanaka K; Shoda J
    JHEP Rep; 2021 Jun; 3(3):100253. PubMed ID: 33898958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.
    Rinaldi R; De Nucci S; Donghia R; Donvito R; Cerabino N; Di Chito M; Penza A; Mongelli FP; Shahini E; Zappimbulso M; Pesole PL; Coletta S; Triggiani V; Cozzolongo R; Giannelli G; De Pergola G
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive approach to lifestyle intervention based on a calorie-restricted diet ameliorates liver fat in overweight/obese patients with NAFLD: a multicenter randomized controlled trial in China.
    Liu Z; Jin P; Liu Y; Zhang Z; Wu X; Weng M; Cao S; Wang Y; Zeng C; Yang R; Liu C; Sun P; Tian C; Li N; Zeng Q
    Nutr J; 2024 Jun; 23(1):64. PubMed ID: 38872173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial.
    Thomsen MN; Skytte MJ; Samkani A; Carl MH; Weber P; Astrup A; Chabanova E; Fenger M; Frystyk J; Hartmann B; Holst JJ; Larsen TM; Madsbad S; Magkos F; Thomsen HS; Haugaard SB; Krarup T
    Diabetologia; 2022 Mar; 65(3):506-517. PubMed ID: 34993571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diet high in α-linolenic acid and monounsaturated fatty acids attenuates hepatic steatosis and alters hepatic phospholipid fatty acid profile in diet-induced obese rats.
    Hanke D; Zahradka P; Mohankumar SK; Clark JL; Taylor CG
    Prostaglandins Leukot Essent Fatty Acids; 2013; 89(6):391-401. PubMed ID: 24140006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet.
    Kabisch S; Bäther S; Dambeck U; Kemper M; Gerbracht C; Honsek C; Sachno A; Pfeiffer AFH
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease-a randomized controlled trial.
    Wang YY; Tian F; Qian XL; Ying HM; Zhou ZF
    Front Nutr; 2024; 11():1439473. PubMed ID: 39229586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial.
    Dashti F; Alavian SM; Sohrabpour AA; Mousavi SE; Keshavarz SA; Esmaillzadeh A
    BMJ Open; 2023 Apr; 13(4):e063988. PubMed ID: 37117000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of intermittent fasting diet in comparison with low-calorie diet on lipid profile, glycemic status, and liver fibrosis in patients with non-alcoholic fatty liver (NAFLD): a study protocol for a randomized controlled clinical trial.
    Karimi M; Nejad MM; Akhgarjand C; Sohrabpour AA; Poustchi H; Imani H; Mohammadi H
    BMC Nutr; 2023 Dec; 9(1):145. PubMed ID: 38066628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (
    Molina-Molina E; Shanmugam H; Di Ciaula A; Grattagliano I; Di Palo DM; Palmieri VO; Portincasa P
    JHEP Rep; 2021 Feb; 3(1):100203. PubMed ID: 33490935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis.
    Haigh L; Kirk C; El Gendy K; Gallacher J; Errington L; Mathers JC; Anstee QM
    Clin Nutr; 2022 Sep; 41(9):1913-1931. PubMed ID: 35947894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.